Sonoma Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of March 2025: 0.09x

Sonoma Pharmaceuticals Inc cash flow reinvestment rate. Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Reinvestment Rate of 0.09x as of March 2025, reinvesting $49.00K (capex $2.00K plus investments $-47.00K) from operating cash flow of $565.00K. Explore Sonoma Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.09x
(Capex + Investments) / Operating CF

Total Reinvested

$49.00K
Capex + Investments

Operating Cash Flow

$565.00K
USD

Capital Expenditures

$2.00K
USD

Cash Flow Reinvestment Rate of Sonoma Pharmaceuticals Inc (2013–2013)

Cash flow reinvestment rate of Sonoma Pharmaceuticals Inc from 2013 to 2013. Historical reinvestment intensity for Sonoma Pharmaceuticals Inc across 1 annual periods. Explore SNOA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Sonoma Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2013–2013)

Sonoma Pharmaceuticals Inc cash flow reinvestment rate by year from 2013 to 2013. Year-by-year capital reinvestment analysis for Sonoma Pharmaceuticals Inc. For the full cash flow conversion analysis, see Sonoma Pharmaceuticals Inc cash flow conversion.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2013 0.22x $257.00K $1.15 Million $257.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow